149 related articles for article (PubMed ID: 35464051)
1. Preclinical
Li Y; Chen Y; Wei M; Wei C
Front Endocrinol (Lausanne); 2022; 13():845404. PubMed ID: 35464051
[TBL] [Abstract][Full Text] [Related]
2. Preclinical findings: The pharmacological targets and molecular mechanisms of ferulic acid treatment for COVID-19 and osteosarcoma
Pang G; Yi T; Luo H; Jiang L
Front Endocrinol (Lausanne); 2022; 13():971687. PubMed ID: 36204096
[TBL] [Abstract][Full Text] [Related]
3. Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin.
Li Y; Yu S; Li Y; Liang X; Su M; Li R
Front Endocrinol (Lausanne); 2021; 12():714909. PubMed ID: 34712201
[TBL] [Abstract][Full Text] [Related]
4. Mogroside V reduce OVA-induced pulmonary inflammation based on lung and serum metabolomics.
Liu Y; Wang J; Guan X; Yu D; Huangfu M; Dou T; Zhou L; Wang L; Liu G; Li X; Zhai Z; Han M; Liu H; Chen X
Phytomedicine; 2021 Oct; 91():153682. PubMed ID: 34483017
[TBL] [Abstract][Full Text] [Related]
5. Exploration of molecular targets and mechanisms of Chinese medicinal formula Acacia Catechu -Scutellariae Radix in the treatment of COVID-19 by a systems pharmacology strategy.
Feng T; Zhang M; Xu Q; Song F; Wang L; Gai S; Tang H; Wang S; Zhou L; Li H
Phytother Res; 2022 Nov; 36(11):4210-4229. PubMed ID: 35859316
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Mogroside V in Siraitia grosvenorii with micelle-mediated cloud-point extraction.
Deng F; Liang X; Yang L; Liu Q; Liu H
Phytochem Anal; 2013; 24(4):381-5. PubMed ID: 23349010
[TBL] [Abstract][Full Text] [Related]
7. A Combined Transcriptomic and Proteomic Approach to Reveal the Effect of Mogroside V on OVA-Induced Pulmonary Inflammation in Mice.
Dou T; Wang J; Liu Y; Jia J; Zhou L; Liu G; Li X; Han M; Lin J; Huang F; Chen X
Front Immunol; 2022; 13():800143. PubMed ID: 35371026
[TBL] [Abstract][Full Text] [Related]
8. Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.
Qin X; Huang C; Wu K; Li Y; Liang X; Su M; Li R
J Cell Mol Med; 2021 Jan; 25(2):677-685. PubMed ID: 33241658
[TBL] [Abstract][Full Text] [Related]
9. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
10. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
12. Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging Cytoskeleton.
Chen J; Jiao D; Li Y; Jiang C; Tang X; Song J; Chen Q
Curr Cancer Drug Targets; 2019; 19(11):885-895. PubMed ID: 31215378
[TBL] [Abstract][Full Text] [Related]
13. A natural food sweetener with anti-pancreatic cancer properties.
Liu C; Dai LH; Dou DQ; Ma LQ; Sun YX
Oncogenesis; 2016 Apr; 5(4):e217. PubMed ID: 27065453
[TBL] [Abstract][Full Text] [Related]
14. Protective activity of mogroside V against ovalbumin-induced experimental allergic asthma in Kunming mice.
Song JL; Qian B; Pan C; Lv F; Wang H; Gao Y; Zhou Y
J Food Biochem; 2019 Sep; 43(9):e12973. PubMed ID: 31489660
[TBL] [Abstract][Full Text] [Related]
15. The mechanism and active compounds of semen
Wang Y; Gu W; Kui F; Gao F; Niu Y; Li W; Zhang Y; Guo Z; Du G
Food Nutr Res; 2021; 65():. PubMed ID: 34908920
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking.
Cai Y; Zeng M; Chen YZ
Ann Palliat Med; 2021 Apr; 10(4):3864-3895. PubMed ID: 33691446
[TBL] [Abstract][Full Text] [Related]
17. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
18. Mogroside V exerts anti-inflammatory effects on fine particulate matter-induced inflammation in porcine alveolar macrophages.
Shen J; Shen D; Tang Q; Li Z; Jin X; Li C
Toxicol In Vitro; 2022 Apr; 80():105326. PubMed ID: 35134483
[TBL] [Abstract][Full Text] [Related]
19. Exploring in vitro, in vivo metabolism of mogroside V and distribution of its metabolites in rats by HPLC-ESI-IT-TOF-MS(n).
Xu F; Li DP; Huang ZC; Lu FL; Wang L; Huang YL; Wang RF; Liu GX; Shang MY; Cai SQ
J Pharm Biomed Anal; 2015 Nov; 115():418-30. PubMed ID: 26280925
[TBL] [Abstract][Full Text] [Related]
20. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
Front Immunol; 2021; 12():769011. PubMed ID: 35069542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
